ASP Isotopes (NASDAQ:ASPI) Trading Down 3.8% – Here’s Why

ASP Isotopes Inc. (NASDAQ:ASPI) was down 3.8% on Tuesday . The company traded as low as $7.42 and last traded at $7.60. Approximately 1,140,043 shares changed hands during mid-day trading, a decline of 26% from the average daily volume of 1,532,086 shares. The stock had previously closed at $7.90.

Analysts Set New Price Targets

ASPI has been the topic of a number of recent research reports. Canaccord Genuity Group restated a “buy” rating and issued a $4.50 target price on shares of ASP Isotopes in a research note on Friday, October 18th. Canaccord Genuity Group started coverage on shares of ASP Isotopes in a report on Friday, October 4th. They set a “buy” rating and a $4.50 price target on the stock. Finally, HC Wainwright decreased their price objective on shares of ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a report on Wednesday, August 7th.

ASP Isotopes Price Performance

The company has a market cap of $508.82 million, a price-to-earnings ratio of -11.80 and a beta of 3.88. The company has a current ratio of 4.00, a quick ratio of 4.00 and a debt-to-equity ratio of 2.06. The company has a fifty day moving average price of $4.65 and a two-hundred day moving average price of $3.77.

ASP Isotopes (NASDAQ:ASPI) last announced its quarterly earnings results on Monday, August 19th. The company reported ($0.24) EPS for the quarter. The business had revenue of $1.02 million for the quarter. As a group, equities research analysts anticipate that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Fiera Capital Corp acquired a new stake in shares of ASP Isotopes during the 3rd quarter worth approximately $723,000. GSA Capital Partners LLP increased its holdings in ASP Isotopes by 96.0% in the third quarter. GSA Capital Partners LLP now owns 770,989 shares of the company’s stock valued at $2,143,000 after purchasing an additional 377,721 shares during the last quarter. Marshall Wace LLP increased its stake in shares of ASP Isotopes by 389.6% in the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock valued at $1,668,000 after acquiring an additional 433,734 shares during the last quarter. Vanguard Group Inc. grew its holdings in ASP Isotopes by 479.1% during the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock valued at $4,217,000 after purchasing an additional 844,705 shares during the period. Finally, Bank of New York Mellon Corp acquired a new stake in ASP Isotopes in the second quarter worth $381,000. Institutional investors and hedge funds own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.